Gustave Roussy, Cancer Campus, Grand Paris

This early-stage study tests whether a single infusion of a patient's own modified immune cells (CAR-T cells) is safe for adults with severe autoimmune diseases like lupus, rheumatoid arthritis, or scleroderma that haven't improved with standard treatments. The main goal is to ch…

This study tests whether the HPV vaccine can prevent the return of high-grade precancerous lesions in people who have already been treated for them. About 984 participants aged 18 to 55 with HPV-related lesions at various sites (cervix, vulva, vagina, penis, anus) will receive ei…

This study tests if a CBD oil drink can reduce joint pain caused by hormone therapy in people with early-stage breast cancer. About 130 participants will receive either CBD or a placebo, then switch, to see if CBD helps with pain and daily activities. The goal is to improve quali…

This study explores whether a digital tool using extended reality (like virtual reality) can help teenagers and young adults who have finished treatment for testicular cancer. Many survivors face long-term physical or emotional challenges that are often overlooked. The tool is de…

This study will follow 1,100 people with advanced neuroendocrine tumors (NETs) to see which treatments or treatment sequences cause the fewest long-term, limiting side effects. The goal is to create a tool that helps doctors choose the best therapy for each patient. Participants …